Defining the Role of Host Factors in Ebola Virus RNA Synthesis
Defining the Role of Host Factors in Ebola Virus RNA Synthesis
批准号:
9312744
负责人:
Douglas J. LaCount
金额:
$74.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAffectAffinityAffinity ChromatographyBindingBinding ProteinsBiochemicalBioinformaticsBiological AssayBiophysicsCell CommunicationCellsCellular biologyCessation of lifeClinicalClinical TrialsCommunitiesComplexDataData SetDemocratic Republic of the CongoDengue VirusDependenceDevelopmentDisease OutbreaksDrug effect disorderEbola virusFiloviridaeFilovirusGenetic TranscriptionGenomic LibraryGenotypeGoalsGuineaHealthHepatitis CHumanIndividualIntegration Host FactorsLibrariesManuscriptsMapsMass Spectrum AnalysisMethodsMissionMolecularMusMutationNational SecurityNetwork-basedPathway interactionsPharmaceutical PreparationsPolymerasePreparationPrincipal InvestigatorProteinsProteomicsRNA InterferenceRNA chemical synthesisRNA interference screenRNA replicationReportingResearchRiskRoleSmall Interfering RNASystems BiologyTechniquesTechnologyTestingTwo-Hybrid System TechniquesViralViral ProteinsVirusVirus DiseasesVirus ReplicationWestern AfricaWorkYeastsZaire Ebola viruscellular imagingdata sharingexperienceexperimental studyfollow-upgammaherpesvirusgenome-widegenome-wide analysishigh throughput screeningimprovedinsightkillingsnovelnovel strategiespathogenprogramsprotein protein interactionscreeningstatisticstranscriptome sequencingvaccine candidatevirus host interactionweb site
中文摘要
项目总监/首席调查员(最后、第一、中间):
该项目的总体目标是确定埃博拉病毒复制所需的细胞蛋白。埃博拉病毒
病毒对人类健康和国家安全构成重大威胁。西非2014年的疫情
感染了28,000多人,造成11,000多人死亡(根据世卫组织的统计数据)。虽然
候选疫苗在临床试验中显示出希望,没有临床批准的药物可用和基本
目前尚缺乏有关埃博拉病毒复制的信息。像所有病毒一样,埃博拉病毒依赖于细胞蛋白质
为了它的复制。这种依赖创造了一个潜在的“阿喀琉斯之踵”,可能被利用来开发新的
治疗埃博拉病毒感染的方法。通过研究埃博拉病毒与宿主细胞的相互作用,我们获得了对
病毒蛋白的作用机制以及病毒与宿主相互作用的策略。
然而,有关埃博拉病毒复制的宿主因素的报道相对较少,而且还没有系统的、基因组-
进行了广泛的分析。为了解决这一差距,我们将应用互补技术来
绘制埃博拉病毒-宿主细胞相互作用的高质量地图。在目标1中,我们进行高含量的基因组-
在BSL4条件下对野生型埃博拉病毒进行宽RNAi筛选以确定需要的新宿主因子
埃博拉病毒复制。进行这种筛选的能力是研究团队独一无二的。因为主持人
在目标2中,siRNA筛查中确定的因素可能直接或间接影响埃博拉病毒的复制
我们建议鉴定与埃博拉病毒复制蛋白结合的细胞蛋白。互补蛋白-
蛋白质相互作用发现技术(酵母双杂交和共亲和纯化加质量
光谱分析)被用来开发比
可以用任何单一的方法来实现。由于埃博拉病毒株的序列不同于
疫情的爆发以及这些基因变化对宿主细胞相互作用的影响尚不清楚,我们系统地
将2014年暴发毒株的宿主细胞结合伙伴与扎伊尔埃博拉病毒(1976)的宿主细胞结合伙伴进行比较。寄主细胞因子
目标1和目标2与目标3中现有的大规模数据集相结合,以开发特定毒株的埃博拉病毒
病毒-宿主细胞蛋白相互作用网络。为了更全面地了解监管的影响
病毒与宿主的相互作用,我们将使用高转录相互作用丰富网络。
吞吐量RNA-从目标1和目标2中选择的宿主因素子集的序列分析。我们的研究团队很好
有资格完成本项目的目标,具备BSL4高通量筛查的专业知识
病毒、病毒-宿主细胞蛋白相互作用、RNA序列分析和基于网络的生物信息学分析。寄主
在项目1和项目3中,将测试这些因素对病毒感染的影响,并以生物物理学为特征
以及核心B和项目2中的结构方法。这些研究将共同开发最全面的
迄今为止对埃博拉病毒与宿主细胞相互作用的分析。数据对本计划的任务是不可或缺的,并且是
预计将在更广泛的埃博拉病毒研究界刺激假说驱动的实验。
0925-0001/0002(08/12版)页面续格式页面
英文摘要
Program Director/Principal Investigator (Last, First, Middle):
The overall goal of this Project is to identify cellular proteins that are required for Ebola virus replication. Ebola
viruses pose significant risks to human health and national security. The 2014 outbreak in Western Africa
infected more than 28,000 people and caused more than 11,000 deaths (per WHO statistics). Although
vaccine candidates are showing promise in clinical trials, no clinically approved drugs are available and basic
information about Ebola virus replication is lacking. Like all viruses, Ebola virus depends on cellular proteins
for its replication. This dependence creates a potential “Achilles heel” that may be exploited to develop new
approaches to treat Ebola virus infections. By studying Ebola virus-host cell interactions, we gain insight into
the mechanisms of action of viral proteins and the strategies that the virus uses to interface with its host.
However, relatively few host factors of Ebola virus replication have been reported and no systematic, genome-
wide analyses have been performed. To address this gap, we will apply complementary technologies to
develop high quality maps of Ebola virus-host cell interactions. In Aim 1 we perform a high content, genome-
wide RNAi screen under BSL4 conditions with wildtype Ebola virus to identify novel host factors required for
Ebola virus replication. The capacity to perform such a screen is unique to the research team. Since the host
factors identified in the siRNA screen could act directly or indirectly to affect Ebola virus replication, in Aim 2
we propose to identify cellular proteins that bind to Ebola virus replication proteins. Complementary protein-
protein interaction discovery technologies (yeast two-hybrid assay and co-affinity purification plus mass
spectrometry) are used to develop a more comprehensive Ebola virus-host cell protein interaction network than
could be achieved with any single approach. Since the sequences of Ebola virus strains differ between
outbreaks and the impact of these genetic changes on host cell interactions is not known, we systematically
compare host cell binding partners of a 2014 outbreak strain to those of Ebola Zaire (1976). Host cell factors
from Aims 1 and 2 are integrated with existing large-scale data sets in Aim 3 to develop strain-specific Ebola
virus-host cell protein interaction networks. To create a more complete understanding of regulatory effects of
the virus-host interactions, we will enrich the network in indirect transcriptional interactions using high-
throughput RNA-seq profiling of a subset of host factors selected from Aims 1 and 2. Our research team is well
qualified to accomplish the goals of this Project, having expertise in high-throughput screening of BSL4
viruses, virus-host cell protein interactions, RNA-Seq profiling, and network-based bioinformatic analyses. Host
factors will be tested for their effects on virus infection in Projects 1 and 3, and characterized by biophysical
and structural methods in Core B and Project 2. Together these studies will develop the most comprehensive
analysis of Ebola virus-host cell interactions to date. The data is integral to the mission of this Program and is
expected to stimulate hypothesis-driven experiments in broader Ebola virus research community.
0925-0001/0002 (Rev. 08/12) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Perturbing virus replication with interfering peptides
-
批准号:10354399
-
项目类别:
-
资助金额:$25.27万
-
财政年份:2022
-
负责人:Douglas J. LaCount
-
依托单位:
Perturbing virus replication with interfering peptides
-
批准号:10613481
-
项目类别:
-
资助金额:$19.87万
-
财政年份:2022
-
负责人:Douglas J. LaCount
-
依托单位:
A temporal view of the Plasmodium-red blood cell interactome
-
批准号:8282783
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2010
-
负责人:Douglas J. LaCount
-
依托单位:
A temporal view of the Plasmodium-red blood cell interactome
-
批准号:8477209
-
项目类别:
-
资助金额:$27.33万
-
财政年份:2010
-
负责人:Douglas J. LaCount
-
依托单位:
A temporal view of the Plasmodium-red blood cell interactome
-
批准号:8090281
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2010
-
负责人:Douglas J. LaCount
-
依托单位:
A temporal view of the Plasmodium-red blood cell interactome
-
批准号:7864488
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2010
-
负责人:Douglas J. LaCount
-
依托单位:
CHARACTERIZATION OF TRYPANOSOMA BRUCEI GP63 PROTEIN
-
批准号:6446633
-
项目类别:
-
资助金额:$2.26万
-
财政年份:2001
-
负责人:Douglas J. LaCount
-
依托单位:
CHARACTERIZATION OF TRYPANOSOMA BRUCEI GP63 PROTEIN
-
批准号:6136273
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2000
-
负责人:Douglas J. LaCount
-
依托单位:
海外基金